Detailed results were presented at the 2025 Conference on Retroviruses and Opportunistic Infections (CROI) in San Francisco. ...

This study that evaluates an annual injection of a pre-exposure prophylaxis medication for HIV has been published in The Lancet and presented simultaneously at the Conference on Retroviruses and ...

Healio will be providing live coverage of the Conference on Retroviruses and Opportunistic Infections, which runs from March 9-12 in San Francisco.

based on this latest study presented at the Conference of Retroviruses and Opportunistic Infections. (The study has not yet been published in a peer-reviewed journal.) Researchers studied more ...

The phase 2 study – reported at the Conference on Retroviruses and Opportunistic Infections (CROI) in Denver, Colorado – looked at the combination of MSD’s experimental long-acting reverse ...